8-38247714-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_015214.3(DDHD2):āc.1127A>Gā(p.Asp376Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,489,866 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_015214.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DDHD2 | NM_015214.3 | c.1127A>G | p.Asp376Gly | missense_variant, splice_region_variant | 10/18 | ENST00000397166.7 | NP_056029.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DDHD2 | ENST00000397166.7 | c.1127A>G | p.Asp376Gly | missense_variant, splice_region_variant | 10/18 | 2 | NM_015214.3 | ENSP00000380352 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00290 AC: 442AN: 152194Hom.: 2 Cov.: 31
GnomAD3 exomes AF: 0.00293 AC: 550AN: 187908Hom.: 0 AF XY: 0.00297 AC XY: 308AN XY: 103790
GnomAD4 exome AF: 0.00429 AC: 5740AN: 1337554Hom.: 10 Cov.: 25 AF XY: 0.00422 AC XY: 2810AN XY: 665698
GnomAD4 genome AF: 0.00290 AC: 442AN: 152312Hom.: 2 Cov.: 31 AF XY: 0.00252 AC XY: 188AN XY: 74472
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 54 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 03, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | DDHD2: BP4, BS2 - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 14, 2016 | - - |
DDHD2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at